The white papers, quality indicators and clinical responsibilitySPENCER, Andrew.Clinical medicine. 2012, Vol 12, Num 1, pp 19-22, issn 1470-2118, 4 p.Article

International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell TransplantationPALUMBO, Antonio; VINCENT RAJKUMAR, S; DIMOPOULOS, Meletios A et al.Journal of clinical oncology. 2014, Vol 32, Num 6, pp 587-600, issn 0732-183X, 14 p.Article

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)PALUMBO, Antonio; BRINGHEN, Sara; ZWEEGMAN, Sonja et al.Blood. 2011, Vol 118, Num 17, pp 4519-4529, issn 0006-4971, 11 p.Article

Simulation of ultrasonic lamb wave generation, propagation and detection for a reconfigurable air coupled scannerDOBIE, Gordon; SPENCER, Andrew; BURNHAM, Kenneth et al.Ultrasonics (Guildford). 2011, Vol 51, Num 3, pp 258-269, issn 0041-624X, 12 p.Article

Thalidomide for treatment of multiple myeloma : 10 years laterPALUMBO, Antonio; FACON, Thierry; BOCCADORO, Mario et al.Blood. 2008, Vol 111, Num 8, pp 3968-3977, issn 0006-4971, 10 p.Article

Basic solid Metamodelling of auxetic cellular solids with differential evolution optimisationLEW, Tze Ling; SCARPA, Fabrizio; SPENCER, Andrew et al.Physica status solidi. B. Basic research. 2008, Vol 245, Num 11, pp 2433-2439, issn 0370-1972, 7 p.Conference Paper

International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma―Related Bone DiseaseTERPOS, Evangelos; MORGAN, Gareth; REIMAN, Tony et al.Journal of clinical oncology. 2013, Vol 31, Num 18, pp 2347-2357, issn 0732-183X, 11 p.Article

Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin LymphomaDICKINSON, Michael; RITCHIE, David; BISHTON, Mark et al.British journal of haematology. 2009, Vol 147, Num 1, pp 97-101, issn 0007-1048, 5 p.Article

Our Space: professional development for new graduates and professionals in AustraliaBRADLEY, Fiona; DALBY, Alyson; SPENCER, Andrew et al.IFLA journal. 2009, Vol 35, Num 3, pp 234-244, issn 0340-0352, 11 p.Article

Extramedullary relapse of multiple myeloma associated with a shift in secretion from intact immunoglobulin to light chainsDAWSON, Mark A; PATIL, Sushrut; SPENCER, Andrew et al.Haematologica (Roma). 2007, Vol 92, Num 1, pp 143-144, issn 0390-6078, 2 p.Article

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple MyelomaDIMOPOULOS, Meletios; SPENCER, Andrew; CORSO, Alessandro et al.The New England journal of medicine. 2007, Vol 357, Num 21, pp 2123-2132, issn 0028-4793, 10 p.Article

Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDACMITHRAPRABHU, Sridurga; KHONG, Tiffany; JONES, Simon S et al.British journal of haematology. 2013, Vol 162, Num 4, pp 559-562, issn 0007-1048, 4 p.Article

Similarities and Differences Between the Flow Factor Method by Patir and Cheng and HomogenizationALMQVIST, Andreas; FABRICIUS, John; SPENCER, Andrew et al.Journal of tribology. 2011, Vol 133, Num 3, issn 0742-4787, 031702.1-031702.5Article

An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myelomaVIJ, Ravi; HORVATH, Noemi; SPENCER, Andrew et al.American journal of hematology. 2009, Vol 84, Num 10, pp 650-656, issn 0361-8609, 7 p.Article

Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposureWANG, Michael; DIMOPOULOS, Meletios A; KNIGHT, Robert D et al.Blood. 2008, Vol 112, Num 12, pp 4445-4451, issn 0006-4971, 7 p.Article

PKC412 demonstrates JNK-dependent activity against human multiple myeloma cellsSHARKEY, Janelle; KHONG, Tiffany; SPENCER, Andrew et al.Blood. 2007, Vol 109, Num 4, pp 1712-1719, issn 0006-4971, 8 p.Article

A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozymeDUMOULIN, Mireille; LAST, Alexander M; WYNS, Lode et al.Nature (London). 2003, Vol 424, Num 6950, pp 783-788, issn 0028-0836, 6 p.Article

Lenalidomide in multiple myeloma: Current status and future potentialHANG QUACH; KALFF, Anna; SPENCER, Andrew et al.American journal of hematology. 2012, Vol 87, Num 12, pp 1089-1095, issn 0361-8609, 7 p.Article

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple MyelomaHENRY, David H; COSTA, Luis; VON MOOS, Roger et al.Journal of clinical oncology. 2011, Vol 29, Num 9, pp 1125-1132, issn 0732-183X, 8 p.Article

Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myelomaHAROUSSEAU, Jean-Luc; DIMOPOULOS, Meletios A; KNIGHT, Robert D et al.Haematologica (Roma). 2010, Vol 95, Num 10, pp 1738-1744, issn 0390-6078, 7 p.Article

A 785 kb deletion of 3p14.1p13, including the FOXP1 gene, associated with speech delay, contractures, hypertonia and blepharophimosisPARIANI, Mitchel J; SPENCER, Andrew; GRAHAM, John M et al.European journal of medical genetics. 2009, Vol 52, Num 2-3, pp 123-127, issn 1769-7212, 5 p.Article

Combined Pegylated Liposomal Doxorubicin and Bortezomib Is Highly Effective in Patients With Recurrent or Refractory Multiple Myeloma Who Received Prior Thalidomide/Lenalidomide TherapySONNEVELD, Pieter; HAJEK, Roman; NAGLER, Arnon et al.Cancer. 2008, Vol 112, Num 7, pp 1529-1537, issn 0008-543X, 9 p.Article

The effect of azacitidine on interleukin-6 signaling and nuclear factor-κB activation and its in vitro and in vivo activity against multiple myelomaKHONG, Tiffany; SHARKEY, Janelle; SPENCER, Andrew et al.Haematologica (Roma). 2008, Vol 93, Num 6, pp 860-869, issn 0390-6078, 10 p.Article

A Multicenter Phase 2 Study of Risk-adjusted Salvage Chemotherapy Incorporating Vinorelbine and Gemcitabine for Relapsed and Refractory LymphomaPASRICHA, Sant-Rayn; GRIGG, Andrew; CATALANO, John et al.Cancer. 2008, Vol 113, Num 11, pp 3192-3198, issn 0008-543X, 7 p.Article

Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma : Combination therapy improves time to progressionORLOWSKI, Robert Z; NAGLER, Arnon; SPICKA, Ivan et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 3892-3901, issn 0732-183X, 10 p.Article